Literature DB >> 26712219

Bevacizumab in Advanced Angiosarcoma: What Is the Reality?

Bivas Biswas1, Deepak Dabkara2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26712219     DOI： 10.1200/JCO.2015.64.2181

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Primary angiosarcoma of the breast-series of 11 consecutive cases-a single-centre experience.

Authors:  M Kunkiel; M Maczkiewicz; A Jagiełło-Gruszfeld; Z Nowecki
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

2.  The prognostic value of pretreatment inflammatory biomarkers in primary angiosarcoma.

Authors:  Manni Wang; Shuang Wu; An Tong; Xiwei Cui; Xuelei Ma
Journal:  Cancer Manag Res       Date:  2019-08-22       Impact factor: 3.989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.